These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 19587641)

  • 21. Stepwise development of MAIT cells in mouse and human.
    Martin E; Treiner E; Duban L; Guerri L; Laude H; Toly C; Premel V; Devys A; Moura IC; Tilloy F; Cherif S; Vera G; Latour S; Soudais C; Lantz O
    PLoS Biol; 2009 Mar; 7(3):e54. PubMed ID: 19278296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct CD1d docking strategies exhibited by diverse Type II NKT cell receptors.
    Almeida CF; Sundararaj S; Le Nours J; Praveena T; Cao B; Burugupalli S; Smith DGM; Patel O; Brigl M; Pellicci DG; Williams SJ; Uldrich AP; Godfrey DI; Rossjohn J
    Nat Commun; 2019 Nov; 10(1):5242. PubMed ID: 31748533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NKT Cells Contribute to the Control of Microbial Infections.
    Vogt S; Mattner J
    Front Cell Infect Microbiol; 2021; 11():718350. PubMed ID: 34595131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [NKT cells: their development, mechanisms and effects of action].
    Bojarska-Junak A; Tabarkiewicz J; Roliński J
    Postepy Hig Med Dosw (Online); 2013 Feb; 67():65-78. PubMed ID: 23475484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unique interplay between sugar and lipid in determining the antigenic potency of bacterial antigens for NKT cells.
    Girardi E; Yu ED; Li Y; Tarumoto N; Pei B; Wang J; Illarionov P; Kinjo Y; Kronenberg M; Zajonc DM
    PLoS Biol; 2011 Nov; 9(11):e1001189. PubMed ID: 22069376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
    Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A
    J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oligoclonality and innate-like features in the TCR repertoire of type II NKT cells reactive to a beta-linked self-glycolipid.
    Arrenberg P; Halder R; Dai Y; Maricic I; Kumar V
    Proc Natl Acad Sci U S A; 2010 Jun; 107(24):10984-9. PubMed ID: 20534460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-181a/b-1 Is Not Required for Innate γδ NKT Effector Cell Development.
    Sandrock I; Ziętara N; Łyszkiewicz M; Oberdörfer L; Witzlau K; Krueger A; Prinz I
    PLoS One; 2015; 10(12):e0145010. PubMed ID: 26673421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Roles of CD1d-restricted NKT cells in the intestine.
    van Dieren JM; van der Woude CJ; Kuipers EJ; Escher JC; Samsom JN; Blumberg RS; Nieuwenhuis EE
    Inflamm Bowel Dis; 2007 Sep; 13(9):1146-52. PubMed ID: 17476670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interview: glycolipid antigen presentation by CD1d and the therapeutic potential of NKT cell activation.
    Kronenberg M
    J Vis Exp; 2007; (10):635. PubMed ID: 18989407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recognition of CD1d-restricted antigens by natural killer T cells.
    Rossjohn J; Pellicci DG; Patel O; Gapin L; Godfrey DI
    Nat Rev Immunol; 2012 Dec; 12(12):845-57. PubMed ID: 23154222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The functions of type I and type II natural killer T cells in inflammatory bowel diseases.
    Liao CM; Zimmer MI; Wang CR
    Inflamm Bowel Dis; 2013 May; 19(6):1330-8. PubMed ID: 23518808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NKT and tolerance.
    Diana J; Beaudoin L; Gautron AS; Lehuen A
    Methods Mol Biol; 2011; 677():193-206. PubMed ID: 20941612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double-positive thymocytes select mucosal-associated invariant T cells.
    Seach N; Guerri L; Le Bourhis L; Mburu Y; Cui Y; Bessoles S; Soudais C; Lantz O
    J Immunol; 2013 Dec; 191(12):6002-9. PubMed ID: 24244014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bacillus anthracis lethal toxin disrupts TCR signaling in CD1d-restricted NKT cells leading to functional anergy.
    Joshi SK; Lang GA; Larabee JL; Devera TS; Aye LM; Shah HB; Ballard JD; Lang ML
    PLoS Pathog; 2009 Sep; 5(9):e1000588. PubMed ID: 19779559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of CD1d- and MR1-Restricted T Cells in Asthma.
    Iwamura C; Nakayama T
    Front Immunol; 2018; 9():1942. PubMed ID: 30210497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural killer T cells and ulcerative colitis.
    Lai LJ; Shen J; Ran ZH
    Cell Immunol; 2019 Jan; 335():1-5. PubMed ID: 30638678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Scavenger receptors target glycolipids for natural killer T cell activation.
    Freigang S; Landais E; Zadorozhny V; Kain L; Yoshida K; Liu Y; Deng S; Palinski W; Savage PB; Bendelac A; Teyton L
    J Clin Invest; 2012 Nov; 122(11):3943-54. PubMed ID: 23064364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enterogenous bacterial glycolipids are required for the generation of natural killer T cells mediated liver injury.
    Wei Y; Zeng B; Chen J; Cui G; Lu C; Wu W; Yang J; Wei H; Xue R; Bai L; Chen Z; Li L; Iwabuchi K; Uede T; Van Kaer L; Diao H
    Sci Rep; 2016 Nov; 6():36365. PubMed ID: 27821872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Defining a novel subset of CD1d-dependent type II natural killer T cells using natural killer cell-associated markers.
    Singh AK; Rhost S; Löfbom L; Cardell SL
    Scand J Immunol; 2019 Sep; 90(3):e12794. PubMed ID: 31141185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.